Washington, D.C. 20549

           {X} Quarterly report pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                For the quarterly period ended March 31, 2004


          { } Transition report pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

             For the transition period____________to_______________

                         Commission file number 0-27175

                           ADVANCE TECHNOLOGIES, INC.
             (Exact name or registrant as specified in its charter)

            Nevada                                               95-4755369
______________________________                               ___________________
 (State or other jurisdiction                                 (I.R.S. Employer
Incorporation or organization)                               Identification No.)

                            716 Yarmouth Rd Suite 215
                         Palos Verdes Estates, CA 90274
                    (Address of principal executive offices)

Registrant's telephone number, including area code: (310) 265-7776

Indicate by check mark whether the registrant (1) has filed all reports Required
to be filed by Section 13 or 15(d) of the Securities Exchange Act Of 1934 during
the preceding 12 months (or for such that the registrant was Required to file
such reports), and (2) has shorter period been subject to Such filing
requirements for the past 90 days. Yes {X} No { }


Indicate by check whether the registrant has filed all documents And report
required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act
of 1934 subsequent to the distribution of securities Under a plan confirmed by a
court. Yes { } No { }


Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

As of March 31, 2004, approximately 22,897,717 shares of the Registrant's Common
Stock, $0.001 par value were outstanding. As of March 31, 2004, approximately
38,618,657 shares of the Registrant's Class A Preferred Stock par value $0.001
were outstanding.

                                     Page 1

                                TABLE OF CONTENTS


Cover Page                                                                    1
Part I                                                                        2
Financial Statement Item                                                      2
Financial Statements                                                          3
Balance Sheet                                                                 4
Income Statement                                                              5
Cashflow Statement                                                            6
Financial Footnotes                                                           7
Management Discussion                                                         7
Announcements                                                                 8
Business Overview                                                             8
Actions, Board of Directors                                                  10
Signatures                                                                   10


                                     Page 2


                           ADVANCE TECHNOLOGIES, INC.

                          (A Development Stage Company)

                        Consolidated Financial Statements

                                 March 31, 2004

                           Chisholm & Associates, CPA
                                  PO Box 540216
                            North Salt Lake, UT 84054
                               Tel: (801) 292-8756

                                     Page 3

                           ADVANCE TECHNOLOGIES, INC.
                          (a Development Stage Company)
                           Consolidated Balance Sheets

                                                                         December 31,       September 30,
                                                                             2003               2003
                                                                         ____________       _____________


Current Assets
  Cash                                                                    $  51,581          $  (2,029)
                                                                          _________          _________

Total Current Assets                                                         51,581             (2,029)
                                                                          _________          _________

Property & Equipment, Net                                                    12,476             14,440
                                                                          _________          _________

    Total Assets                                                          $  64,057          $  12,411
                                                                          =========          =========


Current Liabilities
  Accounts Payable                                                        $       -          $   9,637
  Accrued Interest                                                                -                  -
  Note Payable - Officer                                                     46,800             46,800
  Advance Royalties                                                          25,000             25,000
                                                                          _________          _________

Total Current Liabilities                                                    71,800             81,437
                                                                          _________          _________

Long Term Liabilities
  Line of Credit                                                                  -                  -
                                                                          _________          _________

Total Long Term Liabilities                                                       -                  -
                                                                          _________          _________

    Total Liabilities                                                        71,800             81,437
                                                                          _________          _________

Stockholders' Equity
  Common Stock, Authorized 100,000,000 Shares of $.001 Par Value,
    Issued and Outstanding 17,218,967 shares                                 22,766             22,766
  Preferred Stock, Series A Authorized 100,000,000 Shares of $.001
    Par Value, Issued and Outstanding 38,858,057 Shares                      38,748             38,749
  Additional Paid in Capital                                                549,780            549,780

  Deficit Accumulated During the Development Stage                         (619,037)          (680,321)
                                                                          _________          _________

Total Stockholders' Equity                                                   (7,743)           (69,026)
                                                                          _________          _________

    Total Liabilities and Stockholders' Equity                            $  64,057          $  12,411
                                                                          =========          =========

                                     Page 4

                           Advance Technologies, Inc.
                          (a Development Stage Company)
                      Consolidated Statements of Operations

                                                                                 From the beginning
                                          For the three      For the three      of Development stage
                                          months ended       months ended         October 1, 1985
                                          December 31,       December 31,        thru December 31,
                                           2003               2002                  2003
                                          _____________      _____________      ____________________

Revenues                                   $   122,205        $     1,648             $ 182,229

Operating Expenses
  Depreciation & Amortization                    1,964              1,964                39,410
  Oranization Costs                                  -                  -                11,331
  Research & Development                             -                  -                72,750
  General & Administrative                      58,957              4,605               691,809
                                           ___________        ___________             _________

    Total Operating Expenses                    60,921              6,569               815,300
                                           ___________        ___________             _________

Operating Income (Loss)                         61,284             (4,921)             (633,071)
                                           ___________        ___________             _________

Other Income (Expense)
   Miscellaneous Income                              -                  -                98,000
   Interest Expense                                  -             (2,565)              (23,267)
                                           ___________        ___________             _________

    Total Other Income (Expense)                     -             (2,565)               74,733
                                           ___________        ___________             _________

Net Income (Loss)                          $    61,284        $    (7,486)            $(558,338)
                                           ===========        ===========             =========

Net Income (Loss) Per Share                $      0.00        $     (0.00)            $   (0.23)
                                           ===========        ===========             =========

Weighted Average Shares Outstanding         22,766,317         17,218,967             2,424,076
                                           ===========        ===========             =========

                                     Page 5

                           Advance Technologies, Inc.
                          (a Development Stage Company)
                      Consolidated Statements of Cash Flows

                                                                         For the three months ended     From the beginning
                                                                                December 31,            of development stage
                                                                         __________________________     October 1, 1985
                                                                          2003                2002      thru December 31, 2003
                                                                         _______            _______     ______________________

Cash Flows from Operating Activities

  Net Income (Loss)                                                      $61,284            $(7,486)          $(558,338)
  Adjustments to Reconcile Net Loss to Net Cash
    Provided by Operations:
     Depreciation & Amortization                                           1,963              1,964              39,409
     Stock Issued for Services                                                 -                  -             403,025
     Organization Costs                                                        -                  -              11,331
     Decrease in Prepaids                                                      -                  -              14,680
  Change in Assets and Liabilities                                             -                  -                   -
     Increase in Deferred Income                                               -                  -                   -
     Increase (Decrease) in Accounts Payable and Accrued Expenses         (9,637)             2,565              23,274
                                                                         _______            _______           _________

  Net Cash Provided(Used) by Operating Activities                         53,610             (2,957)            (66,619)
                                                                         _______            _______           _________

Cash Flows from Investing Activities
  Investment in Subsidiary                                                     -                  -                 286
  Purchase of Equipment                                                        -                  -             (39,386)
                                                                         _______            _______           _________

  Net Cash Provided (Used) by Investing Activities                             -                  -             (39,100)
                                                                         _______            _______           _________

Cash Flows from Financing Activities
  Payments for Officer Loan                                                    -                  -             (41,200)
  Proceeds from Officer Loan                                                   -                  -              88,000
  Proceeds from Line of Credit                                                 -              4,500              85,500
  Proceeds from Issuance of Stock                                              -                  -              25,000
                                                                         _______            _______           _________

  Net Cash Provided(Used) by Financing Activities                              -              4,500             157,300
                                                                         _______            _______           _________

Increase (Decrease) in Cash                                               53,610              1,543              51,581
                                                                         _______            _______           _________

Cash and Cash Equivalents at Beginning of Period                          (2,029)             1,719                   -
                                                                         _______            _______           _________

Cash and Cash Equivalents at End of Period                                51,581              3,262           $  51,581
                                                                         =======            =======           =========

Cash Paid For:
  Interest                                                               $     -            $15,695           $  31,097
                                                                         =======            =======           =========
  Income Taxes                                                           $                  $     -           $       -
                                                                         =======            =======           =========

                                     Page 6

                           ADVANCE TECHNOLOGIES, INC.
                          (A Development Stage Company)
                                 March 31, 2004



The information furnished herein was taken from the books and records of the
Company without audit. However, such information reflects all adjustments which
are, in the opinion of management, necessary to properly reflect the results of
the interim period presented. The information presented is not necessarily
indicative of the results from operations expected for the full fiscal year.


The tragic events of September 11, 2001 have produced economic and bureaucratic
shock waves that continue to effect ATI and our strategic plans. As time goes on
the effect on ATI is less and the over-all business recovery is improving. Cost
of capital and venture capital remain difficult in the high technology sector.
US Government restrictions on the application of Infrared Technology to
commercial application continue as we learn to work with new restrictions and
reporting requirements. The commercial applications are becoming easier, export
restriction are more difficult. The effect has been most notable in the decline
of the price of our common stock and a general slow down of our markets.

Advance Technologies has reached an agreement in principle with a marketing and
sales group to launch the NITEAGLE program. Terms of this agreement are expected
to be finalized in April 2004.

The acquisition of Telesis Technologies Inc., a privately held Taiwanese
corporation was officially completed this fall by United Integrated Services
(UIS), a publicly traded Taiwan Corporation. Our agent agreement and joint
projects have been converted to UIS with no change in terms and conditions.

In January 2004 ATI delivered 15 Nightview camera to UIS for their Spectrum 9000
medical system sold in the far east. These units were exported under the terms
of our agent agreement and in compliance with the terms and conditions of
Department of Commerce License No. D293324 issued October 26, 2002. This second
shipment completes the number of systems authorized under the export license.

ATI has applied for another export license for 50 additional IR Cameras. This
will be the third license ATI has obtained for UIS (Telesis).

ATI was contacted by a medical service facility in the USA. The medical company
is interested in conducting clinical trials on the Spectrum 9000 produced by UIS
to investigate potential benefits in the treatment of diabetes, varicose veins,
and other circulatory diseases.


Enhance Vision System, our first project; has entered production. Advance
Technologies benefits through a license agreement with Kollsman Inc.

Kollsman has issued a through March 31, 2004 a total program to date deliveries
and sales.

                                     Page 6

                          ANNUAL UNITS DELIVERED & SOLD

                  INITIAL DELIVERY      UNITS SOLD         TOTAL
                  ________________      __________         _____

Year 2002               47                 29                29
Year 2003              108                107               107
Year 2004 (Q1)          19                 28                28
TOTAL                  174                164               164

The EVS market continues to develop on schedule.

On March 30, 2004 Gulfstream Aerospace announced that they have received an
amendment to the EVS Supplemental Type Certification (STC) for their G-IV
Aircraft. The addition of the G-IV increases the EVS market by more than 500
systems. As a result of this action, Gulfstream now offers EVS as a retrofit on
six models (GIV, GIV-SP, G300, G400, and GV). The retrofit modification is
combined with scheduled maintenance and can be performed at five Service Centers
in the USA. EVS remains standard equipment on G450 & G550 currently in

The proposed rule change (February 2003, Federal Registrar) by the FAA have been
adopted after nearly a year of study and review. The flight rule specifically
approvals EVS for precision approaches in FAA defined low visibility operations.
This rule takes away the last restriction, and EVS can now be expanded beyond
the Business Jet (Part -91 operations) to the Regional Carriers (Part -135),
Major Carriers (Part -121), and the Package Carrier operators (Part -127/-121).

The agreement between Kollsman and FedEx is proceeding with the EVS being slated
for operation on all of FedEx's widebody aircraft.


The advancements in price, performance, and delivery of the microbolometer IR
technology have matured to the point where NITEAGLE is commercially viable. This
long awaited event is key to several commercial applications beyond NITEAGLE.
Details of the final NITEAGLE agreement will be released in our next quarterly


Advanced Technologies is working with a US medical service company to provide a
clinical study, peer group review proposal to study and evaluate potential
benefits to the treatment of circulatory diseases such as varicose veins,
diabetes, and other potential applications. This study will be conducted under
the direction of well recognized Surgeon.

UIS has asked ATI to submit a peer review study proposal. UIS has offered a
Spectrum 9000 to the medical company at a very competitive price. We are still
waiting on the medical company to prepare the "peer group" study proposal. The
medical company has been very busy with their start up, and we expect a firm
proposal to initiate negotiations with UIS. ATI believes the Spectrum 9000 can
be used on a joint basis for the medical company daily business as well as a
"show and tell" demonstrator for the US market.


Advance Technologies Inc. continues development activities on new Infrared
systems for commercial markets. These projects cannot be forecast with any
degree of certainty and all strategic partnerships or business arrangements
remain confidential until such time as a formal announcement is appropriate
without compromising the development plan and/or the application market.


No commitment for capital resources has been made during this reporting period.


The results on the operation represent projects of likely future events that
cannot be guaranteed. Therefore, the financial analysis does not include
projects, and no quantitative assessment has been provided based upon the future
discussion of potential events in section 3.

No material changes have been provided; therefore impact of unforeseeable events
cannot be assessed.

Present financial plans are adequate to meet our cash flow needs with our
current project schedule.

                                     Page 8


The maturity of the Enhanced Vision Project has provided the need to make
adjustments to prepare for our transition from a "development company" to a
mature self-sustaining company. We anticipate a full transition by mid-2004.
Accordingly, the following actions have been authorized by the AVTX Board of
Directors to smooth the transition of AVTX.

On December 14, 2003 the Board of Directors directed the Corporate attorney to
file for authorization to issue 4,000,000 shares of AVTX common stock for the
purpose of generating operating capitol for 2004. The proceeds of sales will be
used to cover operating expense as AVTX completes their transition from a
development company, dependent upon investments to an on-going profitable

In February 2004, the Board of Directors rescinded the direction to the
corporate attorney to file for the issuance of 4,000,000 shares and instructed
the corporate attorney to prepare a Private Placement Memorandum for the private
placement of 4,000,000 common shares subject to Rule 144 restrictions to provide
for operating capital and new business development for 2004. Management believes
this equity placement better suits the company's needs.


Pursuant to the requirement of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                          ADVANCE TECHNOLOGIES, INC.

Date: May 12, 2004                        By: /s/ GARY E. BALL
                                                  Gary E. Ball
                                                  President and Director

                                     Page 9